Changing the structure of PFOA and PFOS: a chemical industry strategy or a solution to avoid thyroid-disrupting effects?
- PMID: 38522066
- PMCID: PMC11266260
- DOI: 10.1007/s40618-024-02339-w
Changing the structure of PFOA and PFOS: a chemical industry strategy or a solution to avoid thyroid-disrupting effects?
Abstract
Background: The family of perfluoroalkyl and polyfluoroalkyl substances (PFAS) raised concern for their proven bioaccumulation and persistence in the environment and animals as well as for their hazardous health effects. As a result, new congeners of PFAS have rapidly replaced the so-called "old long-chain PFAS" (mainly PFOA and PFOS), currently out-of-law and banned by most countries. These compounds derive from the original structure of "old long-chain PFAS", by cutting or making little conformational changes to their structure, thus obtaining new molecules with similar industrial applications. The new congeners were designed to obtain "safer" compounds. Indeed, old-long-chain PFAS were reported to exert thyroid disruptive effects in vitro, and in vivo in animals and humans. However, shreds of evidence accumulated so far indicate that the "restyling" of the old PFAS leads to the production of compounds, not only functionally similar to the previous ones but also potentially not free of adverse health effects and bioaccumulation. Studies aimed at characterizing the effects of new-PFAS congeners on thyroid function indicate that some of these new-PFAS congeners showed similar effects.
Purpose: The present review is aimed at providing an overview of recent data regarding the effects of novel PFAS alternatives on thyroid function.
Results and conclusions: An extensive review of current legislation and of the shreds of evidence obtained from in vitro and in vivo studies evaluating the effects of the exposure to novel PFOA and PFOS alternatives, as well as of PFAS mixture on thyroid function will be provided.
Keywords: Endocrine disruptor; PFOA; PFOS; Thyroid.
© 2024. The Author(s).
Conflict of interest statement
The authors declare they have no competing interests.
Figures

Similar articles
-
The new generation PFAS C6O4 does not produce adverse effects on thyroid cells in vitro.J Endocrinol Invest. 2021 Aug;44(8):1625-1635. doi: 10.1007/s40618-020-01466-4. Epub 2020 Dec 14. J Endocrinol Invest. 2021. PMID: 33315184 Free PMC article.
-
Thyroid Disrupting Effects of Old and New Generation PFAS.Front Endocrinol (Lausanne). 2021 Jan 19;11:612320. doi: 10.3389/fendo.2020.612320. eCollection 2020. Front Endocrinol (Lausanne). 2021. PMID: 33542707 Free PMC article. Review.
-
Transcriptional effects of binary combinations of PFAS in FaO cells.Toxicology. 2021 Dec;464:152997. doi: 10.1016/j.tox.2021.152997. Epub 2021 Oct 22. Toxicology. 2021. PMID: 34695511
-
Developing potency factors for thyroid hormone disruption by PFASs using TTR-TRβ CALUX® bioassay and assessment of PFASs mixtures in technical products.Environ Int. 2021 Dec;157:106791. doi: 10.1016/j.envint.2021.106791. Epub 2021 Aug 4. Environ Int. 2021. PMID: 34364217
-
Perfluoroalkyl Chemicals and Male Reproductive Health: Do PFOA and PFOS Increase Risk for Male Infertility?Int J Environ Res Public Health. 2021 Apr 5;18(7):3794. doi: 10.3390/ijerph18073794. Int J Environ Res Public Health. 2021. PMID: 33916482 Free PMC article. Review.
Cited by
-
Segmentation of Renal Thyroid Follicle Colloid in Common Carp: Insights into Perfluorooctanoic Acid-Induced Morphometric Alterations.Toxics. 2024 May 17;12(5):369. doi: 10.3390/toxics12050369. Toxics. 2024. PMID: 38787148 Free PMC article.
References
-
- Agency LBE (2016) PFOA Und ADONA Messungen an Der Probenahmestelle Alz
-
- ARPAV (2019) Il composto cC6O4 nel Po: i monitoraggi effettuati al 23 luglio 2019
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials